P-PSMA-ALLO1

N/A

Report date: 2024/04/25 11:05:31

Base Information

Drug NameP-PSMA-ALLO1

Drug Alias NamePPSMAALLO-1

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsT lymphocyte replacementsImmunologic cytotoxicity

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPoseida Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesPoseida Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A